$5.44B | |
$109.20 | |
$120.31 | |
$4.03 | |
$112.63 | |
-- | |
0.00% | |
501K |
Celcuity Inc. (CELC) is currently trading at $112.63 as of null, reflecting a 0.00% move ($-0.00) from the previous close.
In the short term, the stock has returned -2.26% over the past four weeks. Over the last 12 months, Celcuity Inc. has recorded a +1,172.66% price change, indicating a strong performance relative to the broader market.
Over the past seven days, Celcuity Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-MEDICAL LABORATORIES sector. During this period, the stock moved from its previous closing price of $106.19 to the latest recorded price of $112.63, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (501,394.20376), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, CELC has delivered a -2.26% return over the past month and a +1,172.66% change in the last 12 months, indicating a strong trend relative to its broader sector peers.
You can buy and trade CELC on MEXC in three simple steps:
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 155 |
| Sector | SERVICES-MEDICAL LABORATORIES |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 CELC = 112.63 USD